Biolin Scientific divests Osstell, focuses on life sciences

Document -

Biolin Scientific divests Osstell, focuses on life sciences

Biolin Scientific (biolinscientific.com) announces today the divestiture of Osstell, a subsidiary focused on dental diagnostic solutions, to the venture capital company Fouriertransform. The transaction price is approximately 33 MSEK (enterprise value) and involves 100% of the shares in Osstell AB. The divestiture of Osstell is expected to be non-dilutive to Biolin Scientific’s EBITA in 2014.
  • License: © All rights reserved
    The Content may only be used by Mynewsdesk. It is thus not permissible for anyone else to download, copy, distribute or otherwise use the Content (other than for private use to the extent permitted by law).
  • File format: .pdf

Contacts

Mattias Bengtsson

Press contact CEO, Biolin Scientific +46 709577337

Related content

Biolin Scientific divests Osstell, focuses on life sciences

Biolin Scientific (biolinscientific.com) announces today the divestiture of Osstell, a subsidiary focused on dental diagnostic solutions, to the venture capital company Fouriertransform. The transaction price is approximately 33 MSEK (enterprise value) and involves 100% of the shares in Osstell AB. The divestiture of Osstell is expected to be non-dilutive to Biolin Scientific’s EBITA in 2014.